Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza announced today the construction of a new small molecule manufacturing complex at its Visp (CH) site.
read more
ADMA Biologics, Inc. has announced commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters plasma collection facility located in Goose Creek, South Carolina.
read more
Samsung Biologics and TG Therapeutics have announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20 monoclonal antibody.
read more
The Decentralized Trials & Research Alliance (DTRA) today announced that it now counts more than 100 member organizations united in the shared mission to make clinical-trial participation widely accessible to patients.
read more
Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine.
read more
InveniAI® LLC has announced a multi-target drug discovery collaboration with Shionogi & Co., Ltd.
read more
ProBioGen announced that Asher Biotherapeutics has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at 1000 L bioreactor scale.
read more
DNA Script has announced a partnership with Moderna, Inc. to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of DARPA's Nucleic Acids On-Demand World-Wide Program.
read more
Sygnature Discovery has established a new office presence in South San Francisco’s biotech hub at Oyster Point, where it can better serve current and future clients on the US west coast.
read more
Wednesday, April 28, 2021
Avantor Inc. announces that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
read more
Wednesday, April 28, 2021
AavantiBio and Catalent have announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies.
read more
ADMA Biologics, Inc. has announced that the FDA has granted approval for the company’s expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of IVIG.
read more
Lonza has announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna.
read more
Catalent and Stirling Ultracold have announced a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.
read more
Albany Molecular Research, Inc. announces expanded access to its accelerated solutions platform, spanning research & development to manufacturing for orphan and rare disease products.
read more